Firehawk Rapamycin Target Eluting Coronary Stent System Features - Video
The Firehawk® stent by MicroPort is the world's first independently developed and commercially successful stent with a groove in the stent strut surface and a targeted release technology. The unique design of Firehawk® where the amount of drug load used is greatly reduced (the drug load is 1/3 of similar products), and the absorbable polymer has the lowest polymer load compared with other biodegradable polymer drug-eluting stents in the world, combine the advantages of both drug eluting stents and bare metal stents. Through the extensive, rigorous clinical study by the “gold standard” randomized controlled trial, the Firehawk® continues to increase the body of clinical evidence for safety and efficacy, further establishing its status as an elite workhorse drug-eluting stent for worldwide use.
-
Most popular related searches
Customer comments
No comments were found for Firehawk Rapamycin Target Eluting Coronary Stent System Features - Video. Be the first to comment!